BUSINESS FDA approves return of popular Primatene Mist asthma inhaler

BUSINESS

FDA approves return of popular Primatene Mist asthma inhaler

AP

07:46, November 09, 2018

800 (17).jpeg

(Photo: AP)

A new version of the once-popular asthma inhaler Primatene Mist will soon return to U.S. stores.

The Food and Drug Administration approved the over-the-counter aerosol inhaler late Wednesday. It’s for temporary relief of mild, intermittent asthma symptoms in people ages 12 and up.

The original Primatene Mist was pulled from store shelves seven years ago because the inhaler’s ozone-depleting propellant had been banned. That version had been marketed for half a century, including in memorable TV ads .

The new product from Amphastar Pharmaceuticals uses a safer propellant. The inhaler will cost about $25 and should be available by the end of the year.

The FDA said in a statement that the inhaler should not be substituted for prescription treatments or used by people with severe asthma.


Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue